GMP‐compliant manufacturing of biologically active cell‐derived vesicles produced by extrusion technology-Reference-Cited by-同舟云学术

GMP‐compliant manufacturing of biologically active cell‐derived vesicles produced by extrusion technology

Published:2022-12 Issue:12 Volume:1 Page:
ISSN:2768-2811
Container-title:Journal of Extracellular Biology
language:en
Short-container-title:J of Extracellular Bio

Author:

Lau Hui‐Chong¹,Han Dong Woo¹,Park Jinhee¹,Lehner Edwine²,Kals Carina²,Arzt Claudia³,Bayer Elisabeth²,Auer Daniela²,Schally Tanja²,Grasmann Eva³,Fang Han³,Lee Jae‐Young⁴,Lee Hyun Soo⁴,Han Jinah⁵,Gimona Mario²³⁶,Rohde Eva²⁷,Bae Shingyu¹,Oh Seung Wook¹⁵^ORCID

Affiliation:

1. BioDrone Research Institute MDimune Inc. Seoul Korea

2. GMP Unit, Spinal Cord Injury & Tissue Regeneration Centre Salzburg (SCI‐TReCS) Paracelsus Medical University Salzburg Austria

3. Transfer Centre for Extracellular Vesicle Theralytic Technologies (EV‐TT) Salzburg Austria

4. Department of Ophthalmology, Eunpyeong St. Mary's Hospital, College of Medicine The Catholic University of Korea Seoul Korea

5. BioDrone Therapeutics Inc. Seattle USA

6. Research Program “Nanovesicular Therapies” Paracelsus Medical University Salzburg Austria

7. Department of Transfusion Medicine, University Hospital Salzburger Landeskliniken GesmbH (SALK) and Paracelsus Medical University Salzburg Austria

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jex2.70

Reference70 articles.

1. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury

2. NG2 as an Identity and Quality Marker of Mesenchymal Stem Cell Extracellular Vesicles

3. Risk of tumorigenicity in mesenchymal stromal cell–based therapies—Bridging scientific observations and regulatory viewpoints

4. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure

5. The Mechanisms of Vesicle Budding and Fusion

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-viral gene therapy for neuromuscular diseases including Duchenne muscular dystrophy using nanovesicles derived from human cells;Rare Disease and Orphan Drugs Journal;2024-09-02

2. Protective effects of mesenchymal stem cells-derived extracellular vesicles against ischemia-reperfusion injury of hearts donated after circulatory death: Preliminary study in a pig model;Biomedicine & Pharmacotherapy;2024-09

3. M1-polarized macrophage-derived cellular nanovesicle-coated lipid nanoparticles for enhanced cancer treatment through hybridization of gene therapy and cancer immunotherapy;Acta Pharmaceutica Sinica B;2024-07

4. Extracellular Vesicles as Next-Generation Diagnostics and Advanced Therapy Medicinal Products;International Journal of Molecular Sciences;2024-06-13

5. Recent Progress of Small Interfering RNA Delivery on the Market and Clinical Stage;Molecular Pharmaceutics;2024-04-17